Susan Slager, PhD

Professor
Department of Quantitative Health Sciences, Division of Hematology, Mayo Clinic

N/A

Poster(s):

• 1502 - Sequencing single novel agent-based therapy for patients with CLL: A retrospective study of patients treated with covalent Bruton Tyrosine Kinase inhibitor (cBTKi) followed by B-cell lymphoma 2 inhibitor (BCL2i) versus BCL2i followed by cBTKi

• 1712 - Other Cancers in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma